Cidara Therapeutics Inc
Biotechnology
Healthcare
CDTX
7.00 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
16.77
52 week high
27.30
high
18.01
52 week low
10.17
low
15.76
growth
37.67 %
previous Close
17.10
P/E ratio
-7
market cap
259 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-15.54 M
82.62 %
eps
-2.45 %
87.74 %
eps surprise
42.35 %
net profit margin
-1553500000.00 %
29605.00 %
operating incoming
-17.39 M
-56.69 %
net change in cash
-36.98 M
-127.32 %
cash on hand
127 M
-22.50 %
cost of revenue
0.00 %
top top